Abstract:Background: Alzheimer disease and related dementias (ADRD) rank as the sixth leading cause of death in the United States, underlining the importance of accurate ADRD risk prediction. While recent advancements in ADRD risk prediction have primarily relied on imaging analysis, not all patients undergo medical imaging before an ADRD diagnosis. Merging machine learning with claims data can reveal additional risk factors and uncover interconnections among diverse medical codes. Objective: The study aims to use graph neural networks (GNNs) with claim data for ADRD risk prediction. Addressing the lack of human-interpretable reasons behind these predictions, we introduce an innovative, self-explainable method to evaluate relationship importance and its influence on ADRD risk prediction. Methods: We used a variationally regularized encoder-decoder GNN (variational GNN [VGNN]) integrated with our proposed relation importance method for estimating ADRD likelihood. This self-explainable method can provide a feature-important explanation in the context of ADRD risk prediction, leveraging relational information within a graph. Three scenarios with 1-year, 2-year, and 3-year prediction windows were created to assess the model's efficiency, respectively. Random forest (RF) and light gradient boost machine (LGBM) were used as baselines. By using this method, we further clarify the key relationships for ADRD risk prediction. Results: In scenario 1, the VGNN model showed area under the receiver operating characteristic (AUROC) scores of 0.7272 and 0.7480 for the small subset and the matched cohort data set. It outperforms RF and LGBM by 10.6% and 9.1%, respectively, on average. In scenario 2, it achieved AUROC scores of 0.7125 and 0.7281, surpassing the other models by 10.5% and 8.9%, respectively. Similarly, in scenario 3, AUROC scores of 0.7001 and 0.7187 were obtained, exceeding 10.1% and 8.5% than the baseline models, respectively. These results clearly demonstrate the significant superiority of the graph-based approach over the tree-based models (RF and LGBM) in predicting ADRD. Furthermore, the integration of the VGNN model and our relation importance interpretation could provide valuable insight into paired factors that may contribute to or delay ADRD progression. Conclusions: Using our innovative self-explainable method with claims data enhances ADRD risk prediction and provides insights into the impact of interconnected medical code relationships. This methodology not only enables ADRD risk modeling but also shows potential for other image analysis predictions using claims data.

ExAD-GNN: Explainable Graph Neural Network for Alzheimer’s Disease State Prediction from Single-cell Data

Regional Brain Fusion: Graph Convolutional Network for Alzheimer's Disease Prediction and Analysis

Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction

Adaptive Gated Graph Convolutional Network for Explainable Diagnosis of Alzheimer's Disease using EEG Data

Self-Explainable Graph Neural Network for Alzheimer Disease and Related Dementias Risk Prediction: Algorithm Development and Validation Study

SCRN: Single-cell Gene Regulatory Network Identification in Alzheimer's Disease

A Novel Graph Neural Network Method for Alzheimer’s Disease Classification

Self-guided Knowledge-Injected Graph Neural Network for Alzheimer's Diseases

Deep Neural Network Classifier for Alzheimer’s Disease

An Interpretable Population Graph Network to Identify Rapid Progression of Alzheimer’s Disease Using UK Biobank

Multi Scale Graph Neural Network for Alzheimer's Disease

A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer's Disease involving data synthesis

Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework

A practical application of generative adversarial networks for RNA-seq analysis to predict the molecular progress of Alzheimer's disease

Interpretable Learning Based Dynamic Graph Convolutional Networks for Alzheimer's Disease Analysis.

Comorbidity-based framework for Alzheimer's disease classification using graph neural networks

A Self-guided Multimodal Approach to Enhancing Graph Representation Learning for Alzheimer's Diseases

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

A Graph Convolutional Network Based on Univariate Neurodegeneration Biomarker for Alzheimer's Disease Diagnosis

Discovery of Genetic Biomarkers for Alzheimer's Disease Using Adaptive Convolutional Neural Networks Ensemble and Genome-Wide Association Studies

SGUQ: Staged Graph Convolution Neural Network for Alzheimer's Disease Diagnosis using Multi-Omics Data